Adam Zaorski

Adam Zaorski is a New York City solo angel investor whose stated areas of activity include data science, psychedelics, and regulatory technology. He invests at pre-seed and seed stage in United States deals, and the available record does not flag a dedicated healthcare AI mandate. The psychedelics overlap suggests some willingness to engage with regulated therapeutics adjacent to mental health, but there is no public portfolio data confirming a pattern of clinical software or diagnostic investments.

Check size is reported as under $250,000, consistent with a typical solo angel ticket. The record does not list named portfolio companies or co-investors, and there is no website or LinkedIn URL provided to triangulate further. Geographic focus appears to be the United States, with a likely New York concentration.

For healthcare AI founders, the most relevant pathway is probably a mental health, regtech-touching, or data-heavy product where his three stated interest areas converge. He is not a likely lead investor for a regulated medical device or a hospital-deployed clinical AI tool, but a smaller co-investor slot in an early round could make sense if the product has a data science core or interacts with regulated workflows. Public information is thin, so any approach should start with a warm introduction and a tightly framed thesis match rather than a generic cold pitch.